The European Union warned Wednesday of a wave of antitrust investigations into major drug makers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire. "Makers of original medicines are actively trying to delay the entry of generic medicines onto their markets," EU Competition Commissioner Neelie Kroes said. She said regulators knew of at least 200 settlement agreements between generic and major drug makers.
July 09, 2009 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The European Union warned Wednesday of a wave of antitrust investigations into major drug makers, saying they were deliberately stalling cheaper generic versions of their own medicines once exclusive patents expire.
“Makers of original medicines are actively trying to delay the entry of generic medicines onto their markets,” EU Competition Commissioner Neelie Kroes said.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers and financiers for the real estate healthcare event of the year!
This event shines a spotlight on how individuals and firms are changing the investment advisory industry where it matters most.
This conference aims to help insurers and litigators better manage complex claims and litigation.
We are seeking two attorneys with a minimum of two to three years of experience to join our prominent and thriving education law practice in...
Description: Fox Rothschild has an opening in the New York office for a Real Estate Litigation Associate with three to six years of commerci...
Downtown NY property and casualty defense law firm seeks a Litigation Associate with 3+ years' experience to become a part of our team! You ...
